Diet pill Acomplia shows strong weight loss in study
Sanofi Aventis reported that the experimental drug Acomplia helped obese participants lose 5 percent or more of body weight, with over 10 percent loss in a third of higher-dose users, and maintained weight loss over two years. The study included 3,040 adults in the United States and Canada and noted improvements in cholesterol and other health metrics.
MENTIONED IN THIS ARTICLE
New Orleans
Sanofi Aventis SA
Acomplia
Sanofi Aventis
United States
Canada
F Xavier Pi-Sunyer
Columbia University
New York
American Heart Association
Douglas Greene
Sanofi-Aventis
Also Mentioned on This Page
THE
Associated Press
Sprint
U.S
Sprint Pcs
Samsung
Ian
Ruidoso
Santa Fe Shopping Center
East 42Nd St
Midland Mall
N. Midkiff
Otter
eSee
Hablames Espanol
Mente
Wach Pune
Ated
Athe Gord
Pet Conners Campy
PT Ees